Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497344 | PMC |
| http://dx.doi.org/10.3904/kjim.2015.30.4.543 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The long-term prognostic value of the framingham risk scoring in patients with myocardial infarction with nonobstructive coronary arteries.
Am J Prev Cardiol
September 2025
Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, No. 167, North Lishi Road, Xicheng District, Beijing 100037, China.
Background: The Framingham Risk Score for Cardiovascular Disease (FRSCVD), based on the Framingham Heart Study, serves as a foundation for many prediction models. However, its applicability in predicting the long-term prognosis of patients experiencing myocardial infarction with nonobstructive coronary arteries (MINOCA) remains uncertain.
Methods: A cohort of 1158 MINOCA patients was enrolled and stratified into three groups based on 10-year FRSCVD risk.
Inducible Ischemia in Asymptomatic Patients With Coronary Chronic Total Occlusions: A Stress CMR Study.
Catheter Cardiovasc Interv
September 2025
IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.
Background: Given the divergence in recommendations regarding the relevance of inducible ischemia regarding the indication to revascularize chronic total occlusions (CTOs) among European and North American guidelines, we aim at investigating the prevalence and the prognostic impact of significant inducible ischemia in an unselected cohort of asymptomatic CTO patients, integrating collateralization status and viability assessment with stress cardiac magnetic resonance (CMR).
Methods: From a cohort of 749 patients referred to our center with a diagnosis of CTO, we retrospectively analyzed 111 asymptomatic individuals who underwent an adenosine stress CMR. The amount of inducible ischemia subtended by the CTO was calculated, as well as the presence of viable myocardium and the collateralization status.
Fatal Umbilical Cord Hemorrhage Triggering Neonatal Demise: Clinicopathological Insights from the Case Analysis.
Int J Womens Health
August 2025
Key Laboratory of Evidence Science (China University of Political Science and Law), Ministry of Education, Beijing, 100088, People's Republic of China.
Background: Umbilical cord hemorrhage (UCH) is a rare but catastrophic obstetric emergency associated with nearly 50% fetal mortality, and its precise pathogenic mechanisms remain elusive in clinical practice. The pathophysiological cascade involves hemorrhagic expansion from ruptured umbilical vessels predominantly the umbilical vein which generates compressive forces on adjacent umbilical arteries within the constrained Wharton's jelly. This acute vascular compromise precipitates the sudden cessation of fetoplacental circulation, culminating in irreversible hypoxic-ischemic injury.
View Article and Find Full Text PDFSafety and efficacy of remote ischaemic preconditioning in diabetic kidney disease: a pilot randomised, parallel-arm, sham-controlled trial protocol.
BMJ Open
September 2025
Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, China
Introduction: Diabetic kidney disease (DKD), characterised by rapid progression and poor prognosis, accounts for approximately 50% of all end-stage renal disease. Remote ischaemic preconditioning (RIP) can reduce the impact of subsequent fatal ischaemic events through brief episodes of ischaemia remote from a target organ. Therefore, we aim to determine whether RIP can slow the renal failure progression in patients with DKD.
View Article and Find Full Text PDFImmediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION-STEMI): a multicentre, non-inferiority, open-label, randomised trial.
Lancet
September 2025
Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Chonnam National University, Gwangju, South Korea. Electronic address:
Background: The optimal timing of complete revascularisation for patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease remains unclear. We aimed to assess whether immediate complete revascularisation was non-inferior to staged complete revascularisation during the index admission.
Methods: We conducted an open-label, randomised, non-inferiority trial at 14 hospitals in South Korea.